Target intelligence / Profile preview

Proline-rich protein 32 (PRR32)

Target: PRR32
Molecular classification: Other

Overview

Proline-rich protein 32 (PRR32, CXorf64) is a poorly characterized human protein, not a known drug or therapeutic target, with low and widespread tissue expression and no defined molecular or disease function.

Other names: CXorf64chromosome X open reading frame 64Cxorf33proline-rich 32PRR32

Biological functions

Protein binding (unspecific)Unknown function

Disease associations

Amyotrophic lateral sclerosis (expression marker)Martin-Probst Syndrome (listed in region, not causal)Wilson-Turner Syndrome (listed in region, not causal)

Beyond the preview

Go deeper on Proline-rich protein 32 (PRR32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline-rich protein 32 (PRR32).

Explore the full profile